Cargando…
Improved access to HIV diagnosis and linkage to antiretroviral therapy among children in Southern Nigeria: a before-after study
BACKGROUND: Globally, two out of five children living with HIV (CLHIV) are unaware of their HIV status, and a little more than 50% are receiving antiretroviral therapy (ART). This paper describes case-finding strategies and their contribution to identifying CLHIV and linking them to ART in Nigeria....
Autores principales: | Nwanja, Esther, Nwaokoro, Pius, Akpan, Uduak, Toyo, Otoyo, Ezeh, Golda, Elechi, Iheanyichukwu, Idiong, Helen, Badru, Titilope, Sanwo, Olusola, Idemudia, Augustine, Pandey, Satish Raj, Khamofu, Hadiza, Bateganya, Moses |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199424/ https://www.ncbi.nlm.nih.gov/pubmed/37210497 http://dx.doi.org/10.1186/s12887-023-04050-w |
Ejemplares similares
-
Reaching Viral Suppression Among People With HIV With Suspected Treatment Failure who Received Enhanced Adherence Counseling in Southern Nigeria: A Retrospective Analysis
por: Akpan, Uduak, et al.
Publicado: (2022) -
Improving access to HIV testing for pregnant women in community birth
centres in Nigeria: an evaluation of the Prevention of Mother-to-Child
Transmission program
por: Nwanja, Esther, et al.
Publicado: (2023) -
Achieving HIV epidemic control through integrated community and facility-based strategies: Lessons learnt from ART-surge implementation in Akwa Ibom, Nigeria
por: Nwaokoro, Pius, et al.
Publicado: (2022) -
Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID‐19 pandemic: descriptive analysis of programmatic data
por: Sanwo, Olusola, et al.
Publicado: (2021) -
How Hypertension Rates and HIV Treatment Outcomes Compare between Older Females and Males Enrolled in an HIV Treatment Program in Southern Nigeria: A Retrospective Analysis
por: Akpan, Uduak, et al.
Publicado: (2023)